Paper35720508
Clozapine blood level assessment using a point-of-care device: feasibility and reliability.
Kamhi-Nesher S and 9 others. Ther Adv Psychopharmacol, 2022. Cited by 8 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clozapine blood level assessment using a point-of-care device: feasibility and reliability. Papers, record 35720508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35720508
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clozapine blood level assessment using a point-of-care device: feasibility and reliability.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27,207,070 | Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use. | Expert Opin Drug Saf | 2016 | https://conductscience.org/library/papers/27207070 | PubMed |
| 2 | 31,075,044 | A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adult patients. | Expert Rev Clin Pharmacol | 2019 | https://conductscience.org/library/papers/31075044 | PubMed |
| 3 | 24,233,347 | Geographic and clinical variation in clozapine use in the United States. | Psychiatr Serv | 2014 | https://conductscience.org/library/papers/24233347 | PubMed |
| 4 | 15,342,212 | Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial. | Thromb Res | 2004 | https://conductscience.org/library/papers/15342212 | PubMed |
| 5 | 33,854,764 | Using a fingerstick test for haematological monitoring in patients treated with clozapine. | Ther Adv Psychopharmacol | 2021 | https://conductscience.org/library/papers/33854764 | PubMed |
| 6 | 27,365,164 | Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole. | Clin Pharmacol Drug Dev | 2016 | https://conductscience.org/library/papers/27365164 | PubMed |
| 7 | 28,910,830 | Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017. | Pharmacopsychiatry | 2018 | https://conductscience.org/library/papers/28910830 | PubMed |
| 8 | 7,840,349 | Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients. | Am J Psychiatry | 1995 | https://conductscience.org/library/papers/7840349 | PubMed |
| 9 | 8,736,614 | Adverse effects of antipsychotic agents. Do newer agents offer advantages? | Drugs | 1996 | https://conductscience.org/library/papers/8736614 | PubMed |
| 10 | 27,307,187 | Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review. | J Clin Psychopharmacol | 2016 | https://conductscience.org/library/papers/27307187 | PubMed |
| 11 | 3,046,553 | Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. | Arch Gen Psychiatry | 1988 | https://conductscience.org/library/papers/3046553 | PubMed |
| 12 | 34,374,073 | Clozapine levels as a predictor for therapeutic response: A systematic review and meta-analysis. | Acta Psychiatr Scand | 2021 | https://conductscience.org/library/papers/34374073 | PubMed |
| 13 | 31,922,669 | 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). | World Psychiatry | 2020 | https://conductscience.org/library/papers/31922669 | PubMed |
| 14 | 20,463,634 | Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007. | Ther Drug Monit | 2010 | https://conductscience.org/library/papers/20463634 | PubMed |
| 15 | 20,202,351 | Patient satisfaction with point-of-care testing in general practice. | Br J Gen Pract | 2010 | https://conductscience.org/library/papers/20202351 | PubMed |
| 16 | 32,569,062 | Comparison of Novel Immunoassay With Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) for Therapeutic Drug Monitoring of Clozapine. | Ther Drug Monit | 2020 | https://conductscience.org/library/papers/32569062 | PubMed |
| 17 | 33,579,175 | Point-of-care measurement of clozapine concentration using a finger-stick blood sample. | J Psychopharmacol | 2021 | https://conductscience.org/library/papers/33579175 | PubMed |
| 18 | 19,595,447 | 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). | Lancet | 2009 | https://conductscience.org/library/papers/19595447 | PubMed |
| 19 | 25,548,103 | Capillary compared to venous blood sampling in clozapine treatment: patients׳ and healthcare practitioners׳ experiences with a point-of-care device. | Eur Neuropsychopharmacol | 2015 | https://conductscience.org/library/papers/25548103 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,744,378 | Acceptability of capillary point-of-care testing: a systematic review. | BMJ Open | 2026 | https://conductscience.org/library/papers/42744378 | PubMed |
| 42,478,867 | Digital and Biomarker-Based Monitoring for Schizophrenia-Treatment Adherence. | Neuropsychopharmacol Rep | 2026 | https://conductscience.org/library/papers/42478867 | PubMed |
| 40,823,919 | Saliva Based Clozapine Therapeutic Drug Monitoring: A Systematic Review. | Pharmacol Res Perspect | 2025 | https://conductscience.org/library/papers/40823919 | PubMed |
| 40,496,008 | Managing ciprofloxacin-clozapine interaction with immunoassay-based monitoring: A case report. | Ment Health Clin | 2025 | https://conductscience.org/library/papers/40496008 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35720508
GET https://conductscience.org/api/papers/v1/35720508/authors